|

neoadjuvant immunotherapy Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Peking University Cancer Hospital & Institute1

Indications

  • Lung Surgery1
  • Neoadjuvant Immunotherapy1
  • Lung Cancer (NSCLC)1
  • Radiotherapy1
  • Lung Cancer1

Other1 trial

Safety, Efficacy, and Survival Outcomes of Neoadjuvant/Induction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.